Assesment of the Functional Activity of Platelets for the Differential Diagnosis of Thrombocytopathies
NCT05654766 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2022-12-16
Summary
The purpose of this study is to develop a highly sensitive method for assessing the functional activity of platelets for use in the differential diagnosis of thrombocytopenia and platelet defects.
Conditions
- Immune Thrombocytopenia
- Thrombocytopathy
- Acute Leukemia
- Hemorrhagic Disorders
Interventions
- DIAGNOSTIC_TEST
-
Flow cytometry
Parameters such as FSC, SSC, median fluorescence of anti CD42b, PAC-1, CD41, CD63, CD62P, as well as Annexin V fluorescence will be assessed.
- DIAGNOSTIC_TEST
-
Platelet aggregation and plasma coagulation
Turbodimetric platelet aggregation test, impedance platelet aggregation test. Standard plasma coagulation test (fibrinogen level, prothrombin test, thrombin time, activated partial thromboplastin time (aPTT)).
Sponsors & Collaborators
-
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology
collaborator OTHER -
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
lead OTHER_GOV
Principal Investigators
-
[email protected] Shamova, Dr · the Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
-
Viacheslav Dmitriev, Dr · Belarussian Research Center for Pediatric Oncology, Hematology and Immunology
Eligibility
- Min Age
- 1 Year
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-01-02
- Primary Completion
- 2024-12-01
- Completion
- 2024-12-31
More Related Trials
-
Diagnostic of Chronic Thrombocytopenia
NCT04071496 ·Status: COMPLETED
-
Towards Improved Diagnostics for Suspected Platelet Function Disorders
NCT05985668 ·Status: RECRUITING
-
Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia
NCT02241031 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.
NCT01933035 ·Status: COMPLETED
-
Prospective Study of Patients With Thrombocytopenia Following HSCT
NCT02487563 ·Status: COMPLETED ·Phase: PHASE3
-
Platelet Volunteers, Longitudinal and Multi-omic Study
NCT07137429 ·Status: RECRUITING
-
A Clinical Study of Herombopag in Tumors-associated Thrombocytopenia
NCT05350956 ·Status: UNKNOWN ·Phase: PHASE2
-
Thrombosomes® in Bleeding Thrombocytopenic Patients
NCT03394755 ·Status: COMPLETED ·Phase: PHASE1
-
Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.
NCT06531018 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation
NCT05727917 ·Status: UNKNOWN ·Phase: NA
-
The SOLID Platelet Study
NCT03712618 ·Status: TERMINATED ·Phase: PHASE2
-
Pathogen Reduction Evaluation & Predictive Analytical Rating Score
NCT02783313 ·Status: COMPLETED ·Phase: NA
-
Strategies for Transfusion of Platelets (SToP)
NCT00420914 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
NCT00037791 ·Status: COMPLETED ·Phase: PHASE3
-
End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia
NCT01386723 ·Status: TERMINATED
-
Safety and Efficacy of Eltrombopag at Escalated Doses
NCT01880047 ·Status: COMPLETED ·Phase: PHASE2
-
PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer
NCT04842760 ·Status: UNKNOWN
-
Efficacy and Safety of Autologous Cryopreserved Platelets in Patients With PTR
NCT05761457 ·Status: UNKNOWN ·Phase: NA
-
Study on the Safety and Efficacy of Cryopreserved Platelets in Hypoproliferative Thrombocytopenic Patients
NCT05067608 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hetrombopag for Lower-risk MDS With Thrombocytopenia: a Prospective,Open-label, Single-arm Study.
NCT05392647 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma
NCT00151866 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Performance Evaluation of T-TAS 01 PL Chip
NCT03621020 ·Status: COMPLETED
-
A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia
NCT03806556 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation
NCT00903929 ·Status: COMPLETED ·Phase: PHASE1
-
Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia
NCT03195010 ·Status: TERMINATED ·Phase: PHASE2